Usana Insider Gil Fuller Makes Over $1.2 Million on Recent Stock Sales

With the recent settlement of the lawsuit Usana Health Sciences (NASDAQ:USNA) filed against Barry Minkow and Fraud Discovery Institute, the company’s stock price got a nice little boost. And just in time for retiring CFO Gil Fuller to cash in some of his stock options for a tidy little profit …

Usana executives aren’t the only ones lying about their credentials

See! Usana Health Sciences (NASDAQ: USNA) CFO Gill Fuller was right when he said that everyone was lying about their credentials (including him!). The CEO of CellCyte (Public, OTC:CCYG) was recently busted for embellishing his resume, and the stockholders have paid dearly. Gary Reys, the co-founder and CEO of CellCyte …

Gil Fuller, CFO of Usana, Says Almost No One Wants to Make Money in Usana Anyway

Almost none of the business builders want to make money anyway, according to CFO Gil Fuller, so no one need worry. He says that only about 12% of Usana associates want to actually make any money, and only about half of those actually try to make money. Here are a …